News | April 28, 2014

Gooch & Housego Lead MINERVA (MId- To NEaR Infrared Spectroscopy For improVed Medical diAgnostics) Project Wins Photonics Innovation Village Award At Photonics Europe

Source: Gooch & Housego PLC

MINERVAresize_103442

The Gooch & Housego lead MINERVA (MId- to NEaR infrared spectroscopy for improVed medical diAgnostics) project has won a 1500€ prize at SPIE’s recent Photonics Europe conference in Brussels. The award, in the Photonics Innovation Village was for "Best Innovation by a Multilateral Project, Organization or Company" and was accepted on behalf of G&H and other participants by G&H Research Engineer Gary Stevens.

The MINERVA (MId- to NEaR infrared spectroscopy for improVed medical diAgnostics) project is funded with 7.3 M€ under the European Commission’s Seventh Framework Program (FP7-ICT) and runs from November 2012 until October 2016. Project cost 10.6 M€.

In recent years it has become clear that mid-IR imaging spectroscopy has the potential to open a new chapter in bio-medical imaging and offers an effective tool for early cancer diagnosis and improved survival rates. Rather than a search for “cancer marker” absorption peaks, great progress has been made by analyzing the entire bio-molecular mid-IR spectral signature using automated algorithms. However, the lack of suitable sources, detectors and components has restricted the technology to one of academic interest, based on weak thermal sources, low power lasers or synchrotron research tools. For the first time the photonic technology is in place to develop a new mid-IR technology platform on which entirely novel supercontinuum sources (c. 1000x brighter than thermal sources) covering the whole range from 1.5 to 12 μm.

Clinical trials of a MINERVA based system will start within the next few months although the goal of developing an in vivo scanning system to probe patients is still some way off.

According to Professor Nicholas Stone, Professor of Biomedical Imaging and Biosensing at the University of Exeter’s School of Physics: “The field of vibrational spectroscopy applied to medicine is rapidly advancing and many groups have now demonstrated the capability of mid-infrared imaging to identify subtle disease specific changes in the molecular composition of tissues and cells. The MINERVA project will take this technique to the next level by enabling it to be utilized much more rapidly, by developing bright IR sources and sensitive detector arrays we expect to be able to capture diagnostic images of unstained tissues and cells in a matter of seconds. In addition clever data analysis methods will allow the image to be superimposed on each other and standard histopathology images of the same sample. The potential for revolutionizing the current methods of clinical diagnosis are huge.”

The MINERVA project runs until 2015 and is led by optical technology providers Gooch & Housego. Other participants include:

BBT Materials Processing SRO, Danmarks Tekniske Universitet, Gloucestershire Hospitals NHS Foundation Trust, IRNOVA AB, LISA Laser Products OHG, NKT Photonics A/S, Universitat Politècnica de València, University of Exeter, University of Nottingham, Vivid Components, Westfälische Wilhelms-Universität Münster, Xenics NV. For more information, visit MINERVA wesbite (http://minerva-project.eu/).

About Gooch & Housego
Gooch & Housego is an integrated supplier of critical photonic solutions: optical components, assemblies and sub-systems to the Aerospace, Defense, Industrial, Life Science and Scientific Research sectors, providing world leading enabling design, development and manufacturing expertise across a broad and complementary range of technologies:

  • Acousto-Optics
  • Crystal Optics
  • Electro-Optics
  • Fiber Optics
  • Optical radiation measurement instrumentation
  • Precision Optics and Coatings
  • RF Electronics
  • Wave Plates

Founded in 1948, G&H has six manufacturing sites in the USA and three in the United Kingdom in addition to sales offices in China, France, Germany and Japan and an extensive network of distributors and representatives. For more information, visit www.goochandhousego.com.

SOURCE: Gooch & Housego PLC